These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Transferrin and iron in normal, Alzheimer's disease, and Parkinson's disease brain regions. Loeffler DA; Connor JR; Juneau PL; Snyder BS; Kanaley L; DeMaggio AJ; Nguyen H; Brickman CM; LeWitt PA J Neurochem; 1995 Aug; 65(2):710-24. PubMed ID: 7616227 [TBL] [Abstract][Full Text] [Related]
26. Competition of iron and aluminum for transferrin: the molecular basis for aluminum deposition in iron-overloaded dialysis patients? Van Landeghem GF; D'Haese PC; Lamberts LV; De Broe ME Exp Nephrol; 1997; 5(3):239-45. PubMed ID: 9208284 [TBL] [Abstract][Full Text] [Related]
27. Iron absorption and hepatic iron uptake are increased in a transferrin receptor 2 (Y245X) mutant mouse model of hemochromatosis type 3. Drake SF; Morgan EH; Herbison CE; Delima R; Graham RM; Chua AC; Leedman PJ; Fleming RE; Bacon BR; Olynyk JK; Trinder D Am J Physiol Gastrointest Liver Physiol; 2007 Jan; 292(1):G323-8. PubMed ID: 16935854 [TBL] [Abstract][Full Text] [Related]
31. [Iron metabolism and its exploration in clinical biology]. Brissot P; Pigeon C; Moirand R; Guyader D; Mendler MH; Sapey T; Deugnier Y; Lescoat G; Loréal O Ann Biol Clin (Paris); 1998 Jul; 56 Spec No():5-10. PubMed ID: 9827209 [No Abstract] [Full Text] [Related]
32. Transferrin C2 and Alzheimer's disease: another piece of the puzzle found? Van Rensburg SJ; Carstens ME; Potocnik FC; van der Spuy G; van der Walt BJ; Taljaard JJ Med Hypotheses; 1995 Apr; 44(4):268-72. PubMed ID: 7666827 [TBL] [Abstract][Full Text] [Related]
33. Aluminum stimulates uptake of non-transferrin bound iron and transferrin bound iron in human glial cells. Kim Y; Olivi L; Cheong JH; Maertens A; Bressler JP Toxicol Appl Pharmacol; 2007 May; 220(3):349-56. PubMed ID: 17376497 [TBL] [Abstract][Full Text] [Related]
34. Aluminum exposure through the diet: metal levels in AbetaPP transgenic mice, a model for Alzheimer's disease. Gómez M; Esparza JL; Cabré M; García T; Domingo JL Toxicology; 2008 Jul; 249(2-3):214-9. PubMed ID: 18571827 [TBL] [Abstract][Full Text] [Related]
35. Aluminum disruption of calcium homeostasis and signal transduction resembles change that occurs in aging and Alzheimer's disease. Walton JR J Alzheimers Dis; 2012; 29(2):255-73. PubMed ID: 22330830 [TBL] [Abstract][Full Text] [Related]
36. Aluminum induced oxidative events and its relation to inflammation: a role for the metal in Alzheimer's disease. Campbell A; Bondy SC Cell Mol Biol (Noisy-le-grand); 2000 Jun; 46(4):721-30. PubMed ID: 10875435 [TBL] [Abstract][Full Text] [Related]
37. Neurofibrillary pathology and aluminum in Alzheimer's disease. Shin RW; Lee VM; Trojanowski JQ Histol Histopathol; 1995 Oct; 10(4):969-78. PubMed ID: 8574016 [TBL] [Abstract][Full Text] [Related]
38. Defective gallium-transferrin binding in Alzheimer disease and Down syndrome: possible mechanism for accumulation of aluminium in brain. Farrar G; Altmann P; Welch S; Wychrij O; Ghose B; Lejeune J; Corbett J; Prasher V; Blair JA Lancet; 1990 Mar; 335(8692):747-50. PubMed ID: 1969510 [TBL] [Abstract][Full Text] [Related]
39. Chromatin structure in Alzheimer's disease: effect on 5' leader sequence for NF-L gene and role of aluminum. McLachlan DR; Lukiw WJ; Mizzen CA; Kruck TP Prog Clin Biol Res; 1989; 317():1061-75. PubMed ID: 2690086 [No Abstract] [Full Text] [Related]
40. Glial cells contribute more to iron and aluminum accumulation but are more resistant to oxidative stress than neuronal cells. Oshiro S; Kawahara M; Kuroda Y; Zhang C; Cai Y; Kitajima S; Shirao M Biochim Biophys Acta; 2000 Nov; 1502(3):405-14. PubMed ID: 11068183 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]